Tenecteplase versus Alteplase for Stroke Thrombolysis Evaluation Trial in the Ambulance (Mobile Stroke Unit—TASTE-A): protocol for a prospective randomised, open-label, blinded endpoint, phase II superiority trial of tenecteplase versus alteplase for ischaemic stroke patients presenting within 4.5 hours of symptom onset to the mobile stroke unit

INTRODUCTION: Mobile stroke units (MSUs) equipped with a CT scanner are increasingly being used to assess and treat stroke patients’ prehospital with thrombolysis and transfer them to the most appropriate hospital for ongoing stroke care and thrombectomy when indicated. The effect of MSUs in both re...

Descripción completa

Detalles Bibliográficos
Autores principales: Bivard, Andrew, Zhao, Henry, Coote, Skye, Campbell, Bruce, Churilov, Leonid, Yassi, Nawaf, Yan, Bernard, Valente, Michael, Sharobeam, Angelos, Balabanski, Anna, Dos Santos, Angela, Ng, Felix, Langenberg, Francesca, Stephenson, Michael, Smith, Karen, Bernard, Steve, Thijs, Vincent, Cloud, Geoffrey, Choi, Philip, Ma, Henry, Wijeratne, Tissa, Chen, Chushuang, Olenko, Liudmyla, Davis, Stephen M, Donnan, Geoffrey A, Parsons, Mark
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Neurology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9058803/
https://www.ncbi.nlm.nih.gov/pubmed/35487712
http://dx.doi.org/10.1136/bmjopen-2021-056573

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9058803/
https://www.ncbi.nlm.nih.gov/pubmed/35487712
http://dx.doi.org/10.1136/bmjopen-2021-056573

Ejemplares similares